UCSF Neurological Surgery faculty since 2001
 
Dr. Banerjee is a pediatrician with fellowship training in pediatric hematology and oncology. She is also an epidemiologist and has a special interest in pediatric palliative care. She currently works with Dr. Michael Prados in Pediatric Brain Tumor Consortium clinical trials. Dr. Banerjee's research at present involves the use of novel convection-enhanced delivery of novel drugs for treatment of high-grade glioma, and the role of signal transduction inhibitors with radiation for the treatment of brainstem glioma.
 
Education, Training, and Previous Positions
 
1987: BA, Stanford University
1990: MPH, Tulane School of Public Health
1992: MD, Tulane School of Medicine
1992-1996: Residency in Pediatrics, UCSF
1996-1999: Clinical Fellow, Pediatric Hematology and Oncology, UCSF
1999-2001: Assistant Clinical Professor of Pediatrics, UCSF
 
Selected Professional Memberships and Appointments
 
American Association for Cancer Research
American Society of Clinical Oncology
Children's Oncology Group
Pediatric Brain Tumor Consortium
Society for Neuro-Oncology
The American Society of Pediatric Hematology/Ooncology
 
Contact
 
Anuradha Banerjee MD, MPH
University of California, San Francisco
Department of Neurological Surgery
505 Parnassus Ave., M653
San Francisco, CA 94143-0106
Phone: (415) 353-3489 (academic)
            (415) 353-2193 (clinical)
 
Selected Recent Publications
 
Pang J, Banerjee A, Tihan T. The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms. J Neurooncol 2007; [Epub ahead of print].
 
Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LE. Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. J Clin Oncol 2007;25(21):3137-43.
 
Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol 2007;9(2):145-60.
 
Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol 2006;8(2):166-74.
 
Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;62(1):20-31.